The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein-Protein Interactions

被引：52

作者：

Toure, B. Barry ^{[1
]}

Miller-Moslin, Karen ^{[1
]}

Yusuff, Naeem ^{[1
]}

Perez, Lawrence ^{[1
]}

Dore, Michael ^{[1
]}

Joud, Carol ^{[1
]}

Michael, Walter ^{[1
]}

DiPietro, Lucian ^{[1
]}

van der Plas, Simon ^{[1
]}

McEwan, Michael ^{[1
]}

Lenoir, Francois ^{[1
]}

Hoe, Madelene ^{[1
]}

Karki, Rajesh ^{[1
]}

Springer, Clayton ^{[1
]}

Sullivan, John ^{[1
]}

Levine, Kymberly ^{[1
]}

Fiorilla, Catherine ^{[1
]}

Xie, Xiaoling ^{[1
]}

Kulathila, Raviraj ^{[1
]}

Herlihy, Kara ^{[1
]}

Porter, Dale ^{[1
]}

Visser, Michael ^{[1
]}

机构：

[1] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 02期

关键词：

B cell lymphoma; Bcl-2; family; protein-protein interaction; apoptosis; cancer; DISCOVERY; ANTAGONISTS; PRODRUGS;

D O I：

10.1021/ml300321d

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Overexpression of the antiapoptotic members of the Bcl-2 family of proteins is commonly associated with cancer cell survival and resistance to chemotherapeutics. Here, we describe the structure-based optimization of a series of N-heteroaryl sulfonamides that demonstrate potent mechanism-based cell death. The role of the acidic nature of the sulfonamide moiety as it relates to potency, solubility, and clearance is examined. This has led to the discovery of novel heterocyclic replacements for the acylsulfonamide core of ABT-737 and ABT-263.

引用

页码：186 / 190

页数：5

共 50 条

[1] Small molecule inhibitors of protein-protein interactions: Targeting Bcl-2 family proteins to treat cancer
Elmore, Steven W.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[2] BCL-2 FAMILY PROTEIN INHIBITORS
Krivoshik, A. P.
ANNALS OF ONCOLOGY, 2010, 21 : 25 - 25
[3] Analysis of Bcl-2 family members and protein-protein interactions using novel multiplex immunoassays
Maheshwari, Reeti
Schluter, Melissa
Pepin, Danielle
Hwang, Joseph
CANCER RESEARCH, 2017, 77
[4] The role of the Bcl-2 protein family in cancer
Coultas, L
Strasser, A
SEMINARS IN CANCER BIOLOGY, 2003, 13 (02) : 115 - 123
[5] Protein-protein and protein-lipid interactions of pore-forming BCL-2 family proteins in apoptosis initiation
Sekar, Giridhar
Ojoawo, Adedolapo
Moldoveanu, Tudor
BIOCHEMICAL SOCIETY TRANSACTIONS, 2022, 50 (03) : 1091 - 1103
[6] Identification of inhibitors of Bcl-2 family protein-protein interaction by combining the BRET screening platform with virtual screening
Park, I-Seul
Seo, Haeng Ran
Kim, Kideok
Lee, Honggun
Shum, David
Choi, Inhee
Kim, Jiho
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 527 (03) : 709 - 715
[7] Lipid-Dependent Modulation of Membrane Recruitment and Protein-Protein Interactions in BCL-2 Family of Apoptotic Regulators
Vasquez-Montes, Victor
Vargas-Uribe, Mauricio
Rodnin, Mykola V.
Ladokhin, Alexey
BIOPHYSICAL JOURNAL, 2016, 110 (03) : 255A - 255A
[8] The Bcl-2 protein family
Antonsson, B
Martinou, JC
EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) : 50 - 57
[9] Small molecule inhibitors of BCL-2 protein-protein interactions show anti-tumor activity in nude mice
Beauparlant, P
Attardo, G
Belec, L
Marcellus, R
Chan, H
Jang, A
Steenaart, NAE
Murthy, MSR
Jamali, M
Shore, GC
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S163 - S163
[10] Visualization of Bcl-2 family protein interactions enables screening and characterization of Bcl-2 family small molecule inhibitors in live cells.
Anderson, D.
Wong, C.
Lee, E.
Fairlie, W.
Ludlam, M.
MOLECULAR BIOLOGY OF THE CELL, 2011, 22

← 1 2 3 4 5 →